京都大学医学部附属病院 循環器内科

学会発表(国際学会) – 1996年

  1. Sasayama S: Cytokines in heart failure. University of Adelaide, QueenElizabeth Hospital, Invited Lecture. February 23, Adelaide.
  2. Sasayama S: Immunomodulation as a new therapeutic modality. 6th International Congress on Cardiovascular Pharmacotherapy, Scientific Symposium: Heart Failure:Mechanisms& Management, February 27, Sydney.
  3. Sasayama S: Pharmacology of vesnarinone: A potential cytokine inhibitor. Symposium: Therapies for Heart Failure: A Glimpse into the Failure. March 23, Orlando.
  4. Sasayama S: Immunomodulation and anticytokine therapy for heart failure. 4th World Congress on Heart Failure-Mechanisms and Management, Plenary Lecture. May 27, Jerusalem.
  5. Sasayama S: New insights into pathophysiology ad treatmet of heart failure. Ben-Gurion University of the Negev, Cardiology Division, Invited Lecture. May 28, Beer Sheva.
  6. Sasayama S: Myocardial infarction and coronary collateral circulation. National Taiwan University, Professor H.C.Tsai Memorial Symposium on Acute Myocardial Infarction. October 5, Taipei.
  7. Sasayama S: Immunological aspects of heart failure. Cornell University Medical College, The Howard Gilman Foundation Distinguished Visiting Scientist Lecture. November 15, New York.
  8. Sasayama S: Effects of pimobendan on treatment of heart failure. The 13th Meeting of Japanese Section of the International Society for Heart Research, Pre-congress International Symposium on Inotropic Agents. November 27, Chiba.
  9. Matsumori A: Anticytokine therapy: A new modality of treatment of heart failure. The 6th U.S.-Japan Symposium of Cardiology. Novemver 9, New Orleans.
  10. Yamada T, Wang W, Shioi T, Matsumori A: Apoptosis in congestive heart failure induced by viral myocarditis in mice. The 69th Scientific Sessions of the American Heart Association. November 10-13, New Orleans.
  11. Nakamura T, Yabe D, Shioi T, Furukawa Y, Nakano T, Honjo T: Molecular cloning and expression of a novel FK506-binding protein in murine embryonic heart by the signal sequence trap method. The 69th Scientific Sessions of the American Heart Association. November 10-13, New Orleans.
  12. Shioi T, Matsumori A: Presistent expression of cytokine in the chronic stage of viral myocarditis in mice. The 69th Scientific Sessions of the American Heart Association. November 10-13, New Orleans.
  13. Yamada T, Ono K, Matsumori A, Sasayama S: Fas ligand-fas system is more important in apoptosis than tumor necrosis factor-alpha in congestive heart failure induced by viral myocarditis in mice. The 69th Scientific Sessions of the American Heart Association. November 10-13, New Orleans.
  14. Matsumori A: Cardiac hypertrophy and cell death in viral myocarditis. Pre-congress-symposium, XIIIth Meeting of Japanese Section, International Society for Heart Research. November 27-30, Chiba.
  15. Nawada R, Morita Y, Kouchi I, Akao M, Murakami T: Inhibition of sarcolemmal Na+, K+-ATPase activity reduces the infarct size-limiting effect of preconditioning in rabbit hearts. The 69th Scientific Sessions of American Heart Association. November 10-13, New Orleans.
  16. Muso E, Yodoi J: Detection of serum and renal inflammatory cytokines and ADF/TRX (ATL-derived factor/thioredoxin) in various renal diseases with vasculitis. Third Franco-Japanese Symposium in Nephrology. June 21-23, Reims.
  17. Muso E: Enhanced production of glomerular extracellular matrix in a new mouse strain established by selective mating of high serum IgA ddY (HIGA) mice. Conference de la Commission Rechearche de Centre Hospitalier Universitaire de Grenoble. June 26, Grenoble.
  18. Oyama A, Muso E, Kawamura T, Kamata T, Suyama K, Matsushima H, Yashiro M, Ono T, Yoshida H, Sasayama S: Decreased in vitro production of IL-4 by spleen T lymphocytes from high IgA ddY (HIGA) mice. The 29th Annual Meeting of The American Society of Nephrology. November 3-6, New Orleans.
  19. Suyama K, Sakurai M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S: Specific protective effect on malignant FGS lesion of lipophilic ACE inhibitor (TEMOCAPRIL: TEM) by blocking local renin-angiotensin system (RAS). The 29th Annual Meeting of The American Society of Nephrology. November 3-6, New Orleans.
  20. Kawamura T, Oyama A, Kamata T, Suyama K, Ono T, Muso E, Yoshida H, Sasayama S: Specific contribution of fibronectin to glomerulosclerosis in selectively mated murine high IgA strain (HIGA mice). The 29th Annual Meeting of The American Society of Nephrology. November 3-6, New Orleans.
  21. Matsushima H, Sakurai M, Kawamura T, Kamata T, Muso E, Sasayama S: The effect of recombinant erythropoietin (RHUEPO) administration and of its route on the hemodynamics and renal function in non-dialysed chronic renal failure (ND-CRF) patients. The 29th Annual Meeting of The American Society of Nephrology. November 3-6, New Orleans.
  22. Kamata T, Kawamura T, Matsushima H, Oyama A, Suyama K, Muso E, Sasayama S, Yoshida H: Upregulated glomerular extracellular matrix and TGF-ァ expression associated with marked serum and glomerular immune complexes formation in RF/J mice, a murine model of spontaneous glomerulosclerosis. The 29th Annual Meeting of The American Society of Nephrology. November 3-6, New Orleans.
  23. Yoshida H, Machiguchi T, Tamura T, Yonemoto S, Fukushima H, Minakata T: Urinary TGFβ 1, better than IL-6, reflects clinical and pathological severity of IgA nephropathy. The 29th Annual Meeting of The American Society of Nephrology. November 3-6, New Orleans.
  24. Hata T, Nohara R, Hosokawa R, Fujita M, Kudo T, Tamaki N, Konishi J, Sasayama S: Is syndrom X an ischemic heart disease?: Evaluation by continuous ventricular function monitoring (VEST) and 18fluorodeoxyglucose positron emission CT (PET). The 45th Annual Scientific Session of the American College of Cardiology. March 24-27, Orlando.
  25. Hosokawa R, Nohara R, Okuda K, Fujibayashi Y, Ogino M, Hata T, Fujita M, Tamaki N, Konishi J, Sasayama S: Can the metabolism of I-123 BMIPP reflect ischemia? The 43rd Annual Meeting of the Sopciety of Nuclear Medicine . June 3-6, Denver.
  26. Hata T, Nohara R, Hosokawa R, Kudo Tamaki N, Konishi J, Fujita M: Identification of viable myocardium in patients with old myocardial infarction: Comparison of thallium scintigraphy with reinjection and positron emission tomography with carbon-11 acetate. The 69th Scientific Meeting of the American Heart Association. November 10-13, New Orleans.
  27. LaRovere MT, Mortara A, Bigger TJ, Marcus F, Malik M, Nohara R, schwartz PJ, Camm JA, Hohnloser SH, the ATRAMI investigators: Prognostic value of autonomic markers on life-threatening arrhythmic events after acute myocardial infarction: results from the ATRAMI study. The 69th Scientific Meeting of the American Heart Association. November 10-13, New Orleans.
  28. Cerati D, Mortara A, LaRovere MT, Marcus FI, Malik M, Nohara R, Mazzuero G: Influence of gender on autonomic markers and risk after myocardial infarction in the ATRAMI study. The 69th Scientific Meeting of the American Heart Association. November 10-13, New Orleans.
  29. Horie M: Mg ions and repolarization of cardiac action potential focused on Mg interactions with Ca and channels. (invited lecture) 1996 Gordon Research Conferrnce on MAGNESIUM in Biochemical Processes. January 29-February 3, Ventura.
  30. Ai T, Horie M, Obayashi K, Lai-Hua Xie: “Accentuated antagonism” action of Angiotensin II on cardiac L-type Ca-currents. 1996 AHA Scientific Sessions.November 10-13, New Orleans.
  31. Tsuchiya K, Obayashi K, Watanuki T, Horie M: Does adenosine A1 receptor modulate cardiac ATP-sensitive K channel by increasing subsarcolemmal [ATP]? 1996 AHA Scientific Sessions. November 10-13, New Orleans.
  32. Washizuka T, Lai-Hua Xie, Watanuki M, Horie M: Endothelin-1 inhibits slow component of cardiac delayed rectifier K currents via PTX-sensitive mechanism.(oral presentation) 1996 AHA Scientific Sessions, November 10-13,New Orleans.
  33. Kihara Y, Sasayama S: Amino acid-dependent modulation of calcium versus force relationship in mammalian ventricular myocardium. International Symposium on Inotropic Agents. The 13th Meeting of the Japanese Section of the International Society for Heart Research. October 27, Chiba. Invited Symposist.
  34. Matsuda T, Matoba Y, Sasayama S: Assessment of abnormal thickening of arterial wall in patients with aortitis syndrome by magnetic resonance imaging. Scientific Conference on Current and Future Application of Magnetic Resonance in Cardiovascular Disease. January 14-16, San Francisco.
  35. Matsuda T, Inoue H, Hayashi K, Muramoto S, Komori M, Sasayama S: Segmented burst imaging. Fourth Scientific Meeting, International Society for Magnetic Resonance in Medicine. April 27 – May 3, New York.
  36. Uematsu H, Matsuda T, Inoue H, Hayashi K, Yamada H, Sadato N, Yamamoto K, Yonekura Y, Ishii Y, Yagisawa M: Assessment of renal perfusion using spin-echo and gradient-echo sequence. Fourth Scientific Meeting, International Society for Magnetic Resonance in Medicine. April 27 – May 3, New York.
  37. Uematsu H, Yamada H, Kitagawa A, Yamamori S, Muramoto S, Inoue H, Hayashi K, Matsuda T, Sadato N, Yonekura Y, Ishii Y: Assessment of Hepatic Portal Perfusion Using T2* Measurements of Gd-DTPA. Fourth Scientific Meeting, International Society for Magnetic Resonance in Medicine. April 27 – May 3, New York.
  38. Ono T, Muso E, Sasayama S: Detection of the intact cross linked fibrin in renal biopsy specimens by the antibody DD3B6/22 and plasmin treatment. The XIVth International Fibrinogen Workshop. August 21-23, Canberra.
  39. Ono T, Makino T, Yoshida H, Muso E, Honda G, Sasayama S: Antiproliferative effect of Rosmarinic acid on cultured murine mesangial cells is through inhibition after the point of PKC activation. The Annual Meeting of the American Society of Nephrology. November 3-5, New Orleans.
  40. Hasegawa K, Kitsis NR: Transcriptional coactivator p300 activates muscle-specific gene expression in cardiac myocytes. Scientific Conference on the Molecular Biology of the Normal, Hypertrophied, and Failing Heart. August 21-25, Salt Lake City.
  41. Hasegawa K, Kitsis NR: cis-Acting elements that mediate hemodynamic overload-responsive beta-myosin heavy chain gene expression during cardiac hypertrophy in intact adult rats. The 69th Scientific Sessions American Heart Association. November 10-13, New Orleans.
  42. Hasegawa K, Kitsis NR: Transcriptional coactivator p300 activates muscle-specific gene expression in cardiac myocytes. The 69th Scientific Sessions American Heart Association. November 10-13, New Orleans.
Scroll